T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+15.55%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$883B
AUM Growth
+$883B
Cap. Flow
-$13.3B
Cap. Flow %
-1.51%
Top 10 Hldgs %
35.83%
Holding
3,193
New
153
Increased
2,011
Reduced
801
Closed
135

Sector Composition

1 Technology 34.76%
2 Financials 12.08%
3 Healthcare 10.97%
4 Consumer Discretionary 10.95%
5 Communication Services 10.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GAN
3076
DELISTED
GAN Ltd
GAN
-48,300 Closed -$86K
GLBE icon
3077
Global E Online
GLBE
$5.68B
-35,457 Closed -$1.27M
HBIO icon
3078
Harvard Bioscience
HBIO
$22M
-12,624 Closed -$8K
HEES
3079
DELISTED
H&E Equipment Services
HEES
-24,834 Closed -$2.36M
HLVX icon
3080
HilleVax
HLVX
$105M
-10,063 Closed -$15K
IAUX
3081
i-80 Gold Corp
IAUX
$653M
-142,048 Closed -$83K
IMRX icon
3082
Immuneering
IMRX
$245M
-659,009 Closed -$1M
INMD icon
3083
InMode
INMD
$944M
-28,348 Closed -$503K
INO icon
3084
Inovio Pharmaceuticals
INO
$126M
-15,601 Closed -$26K
INZY
3085
DELISTED
Inozyme Pharma
INZY
-19,533 Closed -$18K
IPSC icon
3086
Century Therapeutics
IPSC
$42.5M
-14,882 Closed -$8K
IVVD icon
3087
Invivyd
IVVD
$204M
-35,716 Closed -$22K
IVW icon
3088
iShares S&P 500 Growth ETF
IVW
$63.1B
-3,836 Closed -$356K
JWN
3089
DELISTED
Nordstrom
JWN
-68,534 Closed -$1.68M
KNSA icon
3090
Kiniksa Pharmaceuticals
KNSA
$2.48B
-16,755 Closed -$373K
LCTX icon
3091
Lineage Cell Therapeutics
LCTX
$267M
-72,398 Closed -$33K
LNZA icon
3092
LanzaTech
LNZA
$49.1M
-52,253 Closed -$13K
LSEA
3093
DELISTED
Landsea Homes
LSEA
-12,433 Closed -$80K
LVO icon
3094
LiveOne
LVO
$63.4M
-35,954 Closed -$26K
LXRX icon
3095
Lexicon Pharmaceuticals
LXRX
$400M
-92,248 Closed -$43K
LYG icon
3096
Lloyds Banking Group
LYG
$64.3B
-902,437 Closed -$3.45M
LYRA icon
3097
Lyra Therapeutics
LYRA
$11.5M
-17,541 Closed -$3K
MGNX icon
3098
MacroGenics
MGNX
$112M
-25,652 Closed -$33K
KG
3099
Kestrel Group, Ltd.
KG
$209M
-68,032 Closed -$39K
MKTW icon
3100
MarketWise
MKTW
$49.6M
-16,037 Closed -$8K